Michael Springer

Title: Michael Springer: Innovator in Norovirus Vaccine Development

Introduction

Michael Springer is an accomplished inventor based in Foxborough, MA (US). He has made significant contributions to the field of vaccine development, particularly focusing on norovirus. His innovative approach has the potential to enhance public health by providing effective immunization against this common virus.

Latest Patents

Michael Springer holds a patent for a dry powder norovirus vaccine. This vaccine comprises at least two norovirus antigens representing different genogroups. The formulation allows for the production of the vaccine using a mixture of different antigens or a combination of monovalent powders, each containing one antigen. The vaccine is designed for mucosal administration and is soluble in aqueous solutions for parenteral administration. The patent also outlines a method of immunization that includes multiple administrations via both mucosal and parenteral routes to maximize immune responses and protection against norovirus infections. He has 1 patent to his name.

Career Highlights

Michael Springer is currently employed at Resilience Government Services, Inc., where he continues to work on innovative solutions in vaccine technology. His expertise in immunology and vaccine formulation has positioned him as a key player in the field.

Collaborations

Some of his notable coworkers include Ron Cobb and Yawei Ni, who contribute to the collaborative efforts in research and development at Resilience Government Services, Inc.

Conclusion

Michael Springer is a dedicated inventor whose work on the norovirus vaccine exemplifies the importance of innovation in public health. His contributions are paving the way for more effective immunization strategies against viral infections.